Edward J. Gane

Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patients.

Ying Zhang, C. Stedman, A. Horban, 2011, Journal of hepatology.